Watchmaker Genomics Launches TAPS+, Expanding Multimodal Capabilities in Oncology Ahead of AMP 2025

Contributed by: Business Wire

Logo

Images

Watchmaker Genomics launches TAPS+, a next-generation technology that unites genetic and epigenetic readouts from the same DNA molecule.

Business Wire embedded0

Tags

Oncology

Health

Genetics

Research

Science

Pharmaceutical

Biotechnology

Watchmaker Genomics

More Like This

Promega and Watchmaker Genomics Announce Strategic Partnership to Advance Molecular Analysis with Next-Generation Reverse Transcriptase

PR Newswire associated0

Epigenica AB Launches the Groundbreaking EpiFinder™ GenomePro - Unlocking the Epigenome with Unprecedented High Throughput and Multiplexing Features

PR Newswire associated0

Bridge Capture™ enables sensitive, scalable liquid biopsy in colorectal cancer pilot

biomodal Delivers the 6-Base Genome with a Powerful New Multiomic Solution, duet evoC

PR Newswire associated0

YourBio Health and RecoveryTrek Partner to Offer Painless and Convenient Alcohol Biomarker Testing

Parse Biosciences Launches Trailmaker Data Analysis Platform to Simplify Single Cell Sequencing

PR Newswire associated0

Molecular diagnostics at the highest level: BIOTYPE launches MODAPLEX platform upgrade for multi-gene testing

PR Newswire associated0

Kinomica Announces Multiple Abstracts on its KScan® Precision Oncology Diagnostic Platform to be Presented at the 72nd Annual Meeting of the American Society for Mass Spectrometry